Tranquilli Financial Advisor’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$611K Sell
7,057
-41
-0.6% -$3.93K 0.36% 68
2025
Q4
$682K Sell
7,098
-81
-1% -$7.87K 0.4% 60
2025
Q3
$684K Sell
7,179
-49
-0.7% -$4.5K 0.4% 63
2025
Q2
$630K Buy
7,228
+303
+4% +$25.7K 0.39% 63
2025
Q1
$622K Buy
6,925
+455
+7% +$40.7K 0.39% 57
2024
Q4
$517K Buy
6,470
+1,242
+24% +$108K 0.33% 65
2024
Q3
$471K Buy
5,228
+65
+1% +$5.47K 0.3% 69
2024
Q2
$398K Buy
5,163
+127
+3% +$10.4K 0.27% 75
2024
Q1
$439K Buy
5,036
+931
+23% +$79.5K 0.29% 72
2023
Q4
$338K Buy
+4,105
New +$313K 0.24% 77

Other funds holding MDT

Tranquilli Financial Advisor's MDT Position: Q1 2026 in Review

Tranquilli Financial Advisor reduced its Medtronic (MDT) stake by 0.58% in Q1 2026, selling an estimated $3.93K and leaving 7,057 shares worth $611K. The position accounts for 0.36% of the portfolio, ranked #68.

Tranquilli Financial Advisor first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $684K in Q3 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Tranquilli Financial Advisor held 7,057 shares of Medtronic worth $611K as of Q1 2026.
  • Tranquilli Financial Advisor sold 41 Medtronic shares in Q1 2026, an estimated $3.93K.
  • Medtronic made up 0.36% of Tranquilli Financial Advisor's portfolio in Q1 2026, its #68 holding.
  • Tranquilli Financial Advisor first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • Tranquilli Financial Advisor's Medtronic position peaked at $684K in Q3 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Tranquilli Financial Advisor's 13F filing for Q1 2026, filed 11 May 2026.